< Back to All Resources
This recent NIDA-funded study examined the use of collaborative care, as compared to traditional care, for patients with opioid (OUD) and alcohol use disorders (AUD) in regards to the treatment received and the likelihood of refraining from substance use six months after the intervention. Collaborative care integrated a six-session brief psychotherapy and/or medications for addiction treatment (MAT) with either buprenorphine/naloxone (for OUD) or long-acting injectable naltrexone (for AUD). Usual care consisted of giving patients a number to schedule an appointment and a list of community referrals for treatment. The study found that patients who received collaborative care were more likely to receive evidence-based treatments and had lower rates of substance use after six months than those who received usual care. Researchers who performed this study suggest that collaborative care for OUD and AUD can be integrated into primary care settings effectively.
External Link
https://www.drugabuse.gov/news-events/news-releases/2017/08/collaborative-care-shows-promise-opioid-alcohol-use-disorders
Related Topics
- Behavioral Health
- Medications for Addiction Treatment (MAT)
- Medical Care